Posted by ABMN Staff on Apr 29th, 2024
Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 382,900 shares, a growth of 49.1% from the March...
More of this article »